Cargando…
Pertussis
Pertussis (whooping cough) is the most frequent vaccine-preventable disease in children less than 5 years old in industrialized countries and has become much more prevalent over the time since the acellular pertussis vaccine replaced the whole cell biologic. The infection has increased in different...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150027/ http://dx.doi.org/10.1016/B978-0-12-416975-3.00027-3 |
_version_ | 1783520938195681280 |
---|---|
author | Lutwick, Larry Preis, Jana |
author_facet | Lutwick, Larry Preis, Jana |
author_sort | Lutwick, Larry |
collection | PubMed |
description | Pertussis (whooping cough) is the most frequent vaccine-preventable disease in children less than 5 years old in industrialized countries and has become much more prevalent over the time since the acellular pertussis vaccine replaced the whole cell biologic. The infection has increased in different age groups and all of these groups can impact on the frequency of disease in infants. It is this group that contributes most of the significant morbidity and mortality of pertussis. The microbiological, clinical, diagnostic, therapeutic, and preventive aspects of Bordetella pertussis infection in man are reviewed and the reasons for this increase in cases including vaccine and pathogen issues are examined. |
format | Online Article Text |
id | pubmed-7150027 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
record_format | MEDLINE/PubMed |
spelling | pubmed-71500272020-04-13 Pertussis Lutwick, Larry Preis, Jana Emerging Infectious Diseases Article Pertussis (whooping cough) is the most frequent vaccine-preventable disease in children less than 5 years old in industrialized countries and has become much more prevalent over the time since the acellular pertussis vaccine replaced the whole cell biologic. The infection has increased in different age groups and all of these groups can impact on the frequency of disease in infants. It is this group that contributes most of the significant morbidity and mortality of pertussis. The microbiological, clinical, diagnostic, therapeutic, and preventive aspects of Bordetella pertussis infection in man are reviewed and the reasons for this increase in cases including vaccine and pathogen issues are examined. 2014 2014-05-16 /pmc/articles/PMC7150027/ http://dx.doi.org/10.1016/B978-0-12-416975-3.00027-3 Text en Copyright © 2014 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Lutwick, Larry Preis, Jana Pertussis |
title | Pertussis |
title_full | Pertussis |
title_fullStr | Pertussis |
title_full_unstemmed | Pertussis |
title_short | Pertussis |
title_sort | pertussis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150027/ http://dx.doi.org/10.1016/B978-0-12-416975-3.00027-3 |
work_keys_str_mv | AT lutwicklarry pertussis AT preisjana pertussis |